Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2017-05-05 Regulatory Filings
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Zmiana istotnej umowy - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is a formal announcement from the Management Board (Zarząd) of Selvita S.A. regarding the signing of an amendment (Aneks) to a framework agreement (Umowa) with a US-based biotech client. The content details the nature of the contract (chemical support for research projects), the term (three years), and the maximum value ($3,110,062.50 USD). This type of disclosure, concerning a significant contract or transaction that impacts the company's operations or financial standing, typically falls under general regulatory disclosures. Since it is not a standard financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a director's dealing (DIRS), it best fits the general regulatory announcement category, which is RNS (Regulatory Filings), as it is a material event disclosure not covered by more specific codes like M&A (TAR) or Capital (CAP). The document length is short (1088 chars), but it is the primary disclosure itself, not an announcement *about* another report.
2017-05-05 Polish
Zawiadomienie Pawła Przewięźlikowskiego
Major Shareholding Notification Classification · 99% confidence The document is a formal notification written in Polish, addressed to Selvita S.A. and the Polish Financial Supervision Authority (Komisia Nadzoru Finansowego). The content explicitly details the 'zbycie akcji' (disposal/sale of shares) by an individual, Paweł Przewięźlikowski, citing specific articles of the Polish Public Offering Act (Ustawa o ofercie publicznej). It quantifies the change in shareholding percentage (from 39.04% to 37.04%) and the number of shares disposed (268,867 shares, representing 2.00% of capital). This type of filing, reporting personal share transactions by directors or major shareholders, directly corresponds to the definition of Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since the notification is about a transaction by an individual who held a controlling stake (over 33% before the transaction, indicating a major shareholder or insider), and it details the change in ownership percentage, it fits best under Major Shareholding Notification (MRQ) or Director's Dealing (DIRS). Given the detailed reporting of percentage changes crossing thresholds, MRQ is highly relevant, but DIRS is often used for executive/director transactions. Since the text focuses on the change in the total holding percentage (crossing thresholds), MRQ is a strong fit, but DIRS is also plausible if the individual is a director. In many regulatory contexts, detailed changes in holdings by insiders/directors are captured under DIRS. However, the structure strongly resembles a notification required when crossing major ownership thresholds (like 5%, 10%, 33%, etc.), which aligns perfectly with Major Shareholding Notification (MRQ). Given the context of reporting personal transactions by an individual whose holding percentage is explicitly detailed before and after the transaction, MRQ is the most precise fit among the options for significant ownership changes.
2017-04-28 Polish
Zawiadomienie od akcjonariusza Spółki - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document text is very short (625 characters) and explicitly states that the company received a notification from a shareholder regarding a change in their voting rights percentage, referencing Polish public offering laws (art. 69 ust. 2 pkt 2 ustawy o ofercie publicznej). It concludes by stating, "Treść zawiadomienia Spółka przekazuje w załączeniu" (The content of the notification is provided in the attachment). This structure—a brief announcement stating that a notification regarding shareholding/voting rights change has been received and is attached—strongly suggests a notification of a change in significant share ownership or voting rights, which aligns best with the Major Shareholding Notification (MRQ) definition, or potentially a general Regulatory Filing (RNS) if MRQ is too specific for foreign filings. Given the content is specifically about a shareholder's voting stake changing, MRQ is the most precise fit, even if the source is Polish.
2017-04-28 Polish
Powiadomienie Tadeusz Wesołowski
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). It details a transaction involving a person discharging managerial responsibilities ("Tadeusz Wesołowski," Vice Chairman of the Supervisory Board) concerning shares of the issuer ("Selvita S.A."). Specifically, it reports the sale ("Zbycie") of 50,000 shares at a price of 55.00 PLN on 2017-04-26. This content directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). Matching this to the provided definitions, Code 9, 'Director's Dealing (Code: DIRS)', is the correct classification.
2017-04-28 Polish
Powiadomienie Tomasz Nocuń
Director's Dealing Classification · 99% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). It details a transaction (Zbycie - Disposal) of shares by a person discharging managerial responsibilities (Tomasz Nocuń, Prokurent, Dyrektor ds. Inwestycji i Rozwoju) in the company Selvita S.A. This type of filing, reporting personal share transactions by directors and executives, directly corresponds to the definition of Director's Dealing (DIRS).
2017-04-28 Polish
Powiadomienie Paweł Przewięźlikowski
Director's Dealing Classification · 99% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of transaction(s) referred to in Article 19(1) of the MAR Regulation). It details a transaction ('Zbycie' - Disposal) involving shares ('akcja') by a person discharging managerial responsibilities ('Paweł Przewięźlikowski', 'Prezes Zarządu' - CEO). Article 19 of MAR (Market Abuse Regulation) mandates reporting of insider transactions by management personnel. This specific type of filing, reporting personal share transactions by directors and executives, directly corresponds to the 'Director's Dealing' category. Code mapping: Director's Dealing corresponds to DIRS.
2017-04-28 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.